Envisagenics
Biotechnology Research
30-02 48th Ave
57 employees
- Employees
- 57
- Contacts
- 3
- Emails
- 3
- Phones
- 2
Envisagenics Overview
- Headquarters
- 30-02 48th Ave
- Phone Number
- Available in AeroLeads
- Website
- envisagenics.com
- Industry
- Biotechnology Research
- Employees
- 57
- Founded
- 2014
- Funding
- 25.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Envisagenics
Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. We focus on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered. Our breakthrough technology, SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence. We are using our software to identify splicing errors causative of diseases, identify the right drug-targets and develop RNA therapeutics through partnerships and collaborations with Biopharma. Our in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost, and failure risk of drug development programs.
Envisagenics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 2
- 50.0% coverage
Envisagenics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Michael Grissinger | Pharmaceutical Executive and Advisor to Life Sciences Companies - Business Strategy & Business Development Expert | Washington Crossing, Pennsylvania, United States |
Email
|
| Sudhir Rao | Chief Business Officer, Envisagenics | Greater Boston, United States |
Email
Phone
|
| Daniella Kranjac | Founding Gp @Avant Bio - Founding Partner @Dynamk Capital | New York, United States |
Email
Phone
|
| Maria Luisa Pineda, Phd. | Vice Chair, Cofounder and Board Member | New York, United States |
View
|
Employees by Management Level
Individual contributor
15 profiles
Senior / Lead
2 profiles
Executive
1 profile
Director
1 profile
Manager
1 profile
Associate / junior
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 7 | 7 | 0 |
| IT | 3 | 3 | 0 |
| Executive | 1 | 1 | 1 |
Envisagenics Tech Stack
Data / AI
4 profiles
Engineering
4 profiles
Compare Similar Companies to Envisagenics
Nuvation Bio
Pharmaceutical Manufacturing
Royalty Pharma
Biotechnology Research
Dianthus Therapeutics, Inc.
Biotechnology Research
Immunic Therapeutics
Biotechnology Research
Lexeo Therapeutics
Biotechnology Research
Protara Therapeutics
Biotechnology Research
Anavex Life Sciences
Biotechnology Research
BioSpherix, LLC
Biotechnology Research
Gilgamesh Pharmaceuticals
Pharmaceutical Manufacturing
Kingdom Supercultures
Biotechnology Research